Clinical results of the EVESOR trial, a multiparameter phase I trial of everolimus and sorafenib combination in solid tumors.
Romain VarnierAlicja PuszkielMichel TodSara CalattiniLea PayenJonathan LopezJérome GuittonVérane SchwiertzJuliette FontaineJulien PeronDenis MailletSophie TartasNathalie BonninOlivier ColombanDiane Augu-DenechereGilles FreyerBenoit YouPublished in: Cancer chemotherapy and pharmacology (2023)
ClinicalTrials.gov Identifier: NCT01932177.